NCT03104855View on ClinicalTrials.gov

Clearance of 25-hydroxyvitamin D in Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

October 9, 2018

Study Completion Date

September 6, 2023

Conditions
Cystic Fibrosis
Interventions
DRUG

d6-25-hydroxyvitamin D3

intravenous administration of stable isotope-labeled D6-25(OH)D3

Trial Locations (1)

98104

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Washington

OTHER

NCT03104855 - Clearance of 25-hydroxyvitamin D in Cystic Fibrosis | Biotech Hunter | Biotech Hunter